ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

LIBRAX
Hyperacidity, GERD, and ulcers
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

LIBRAX CIV

Generic Name and Formulations:
Chlordiazepoxide HCl 5mg, clidinium bromide 2.5mg; caps.

Company:
Valeant Pharmaceuticals, Inc



Therapeutic Use:

Indications for LIBRAX:

Adjunct in peptic ulcer. Irritable bowel syndrome.

Adult Dose for LIBRAX:

1–2 caps 3–4 times daily before meals and at bedtime. Elderly or debilitated: max 2 caps daily initially, then may increase gradually.

Children's Dose for LIBRAX:

Not recommended.

Pharmacological Class:

Benzodiazepine + anticholinergic.

Contraindications:

Glaucoma. GI or GU obstruction.

Warnings/Precautions:

Unstable cardiovascular status. Paralytic ileus or intestinal atony. Toxic megacolon. Severe ulcerative colitis. Myasthenia gravis. Reflux esophagitis. Porphyria. Autonomic neuropathy. Impaired hepatic or renal function. Cardiovascular disease. Hypertension. Hyperthyroidism. Test hepatic function and blood counts in prolonged use. Drug abusers. Suicidal tendencies. High environmental temperature. Diarrhea. Pregnancy (Cat.C), nursing mothers: not recommended.

Interactions:

Concomitant antacids may inhibit absorption. Drowsiness potentiated by other CNS depressants, alcohol. Additive anticholinergic effects with other anticholinergics, narcotic analgesics, type I antiarrhythmics, antihistamines, phenothiazines, tricyclics. Avoid other psychotropic agents.

Adverse Reactions:

Drowsiness, anticholinergic effects, paradoxical excitement, ataxia, confusion. Jaundice, blood dyscrasias (rare).

How Supplied:

Caps—100

LIBRAX

  • 5mg/2.5mg capsules (Qty:90)
  • appx. price $1491.00
GoodRx

Sign Up for Free e-newsletters